Burlat, Diobelyn W.

HRN: 04-08-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2022
CEFTRIAXONE 1G (VIAL)
04/27/2022
05/03/2022
IV
2grams
Q24hrs
Breast CA
Waiting Final Action 
04/27/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/27/2022
05/03/2022
IV
600mg
Q8hrs
Non Healing Wound At Breast, Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: